MBio Diagnostics, Inc. Announces Sue Sutton-Jones Joins as VP of Regulatory Affairs and Quality Assuranc
Published: Apr 09, 2013
BOULDER, CO--(Marketwired - April 09, 2013) -
Commenting on Sue joining MBio, Christopher Myatt, CEO and Founder, noted, "We are pleased to have Sue join the MBio team. She brings a wealth of experience to our mission to increase access to quality healthcare through innovative and low cost point of care diagnostics."
MBio Diagnostics, Inc. (www.mbiodx.com) is a privately held diagnostics and life sciences company based in Boulder, CO. MBio Diagnostics is increasing access to quality healthcare by delivering innovative and low cost point-of-care (POC) diagnostics. The MBio System is initially being commercialized to manage the treatment of HIV patients from a single drop of blood. The MBio elegant detection system is being developed for a broad menu of applications including multiplex assays and cellular analysis.
For more information visit MBio at www.mbiodx.com or contact:
Christopher Myatt, Ph.D.
MBio Diagnostics, Inc.
E-mail: Email Contact